ng28ÄϹ¬ÌåÏÖ£¬½«Ïò¹«ÒæÉçÍÅ·¨ÈËÈ«Çò½¡¿µ¼¼ÊõÕñÐË»ù½ð£¨Global Health Innovative Technology Fund£©ÎªÆÚÎåÄ꣨×Ô2023ÄêÖÁ2027Ä꣩×ܼÆ6.25ÒÚÈÕÔªµÄµÚÈýÆÚ»ù½ð¡£GHIT Fund½¨Á¢ÓÚ2013Äê4Ô£¬ÓÉ°üÀ¨ng28ÄϹ¬ÔÚÄÚµÄÈÕ±¾ÖÆÒ©ÆóÒµ¡¢ÈÕ±¾¹úÕþ¸®¡¢±È¶ûºÍ÷Áմ¸Ç´Ä²ÆÍŵÈÏàÖúͬ°éÅäºÏÉèÁ¢£¬Ö¼ÔÚÔö½øÈÕ±¾ºÍÍâÑóÑо¿»ú¹¹µÄÏàÖú£¬¼ÓËÙÑз¢Õë¶ÔÉú³¤Öйú¼ÒºÍÐÂÐ˹ú¼ÒµÄѬȾ²¡µÄÁ¢ÒìÒ©Îï¡£ng28ÄϹ¬ÒÑÏòGHIT FundÌṩµÚÒ»ÆÚ£¨2013 – 2017Äê¶È£©ºÍµÚ¶þÆÚ£¨2018 – 2022Äê¶È£©»ù½ð¹²¼Æ10ÒÚÈÕÔªµÄ×ʽðÖ§³Ö¡£
ÔÚÉú³¤Öйú¼ÒºÍÐÂÐ˹ú¼Ò£¬Ñз¢ÁÕßÍ´¿àµÄÈÈ´ø²¡£¨NTDs£©ºÍű¼²µÈѬȾ²¡ÁìÓòµÄÐÂҩʱ£¬³ýÁ˼²²¡ÌØÓеÄÀ§ÄÑÓëÊг¡ÐԵȿÎÌâÖ®Í⣬ȷ±£ÍâµØµÄ¹©Ó¦ÌåϵÓëÕïÖεĿɼ°ÐÔÒ²ÊǺÜÒªº¦µÄ¡£Òò´Ë£¬¿Ë·þÕâЩÌôÕ½µÄÒªº¦¾ÍÊÇ¿çÐÐÒµµÄÏàÖú£¬¼´ÆóÒµ½ç-Õþ¸®-ѧÊõ½çµÄÏàÖúͬ°é¹Øϵ¡£
ng28ÄϹ¬ÊÓ½â¾öÈ«ÇòÒ©Æ·¿É¼°ÐÔÎÊÌâΪ¼ºÈΣ¬ÔÚ°üÀ¨Õþ¸®¡¢¹ú¼Ê×éÖ¯ºÍ˽Ӫ·ÇÓªÀû×éÖ¯ÔÚÄڵĹ«Ë½Í¬°éÏàÖú¹ØϵÏ£¬ng28ÄϹ¬¼ÓÈëÁË23¸öÁªºÏÑо¿ÏîÄ¿£¬²¢ÔÚGHIT FundµÄÖ§³ÖÏÂÑз¢ÖÎÁÆ×ã¾úÖס¢Å±¼²ºÍË¿³æ²¡µÄÐÂÒ©ºÍÒßÃç¡£ng28ÄϹ¬Óë·ÇÓªÀû×éÖ¯¡°±»ºöÊÓ¼²²¡Ò©ÎィÒ顱£¨DNDi£©ÏàÖú£¬ÔÚËÕµ¤¿ªÕ¹ÆäÔÑÐÖÎÁÆ×ã¾úÖ×Ò©ÎïIIÆÚÁÙ´²ÊÔÑ顪¡ªE1224£¨Í¨ÓÃÃû£ºfosravuconazole£©¡£ng28ÄϹ¬»¹Óë¿ÏËþ»ù´óѧÏàÖú¿ªÕ¹¿¹Å±Ò©SJ733µÄIIÆÚÁÙ´²ÊÔÑé¡£
ng28ÄϹ¬ÈÏΪ£¬¶Ô±»ºöÊÓµÄÈÈ´ø²¡ºÍű¼²µÈÒ©Æ·µÄÑз¢ÓëÒ©Æ·¿É¼°ÐԵĸÄÉÆ£¬¶¼ÊÇÇкÏng28ÄϹ¬¡°ÌåÌùÈËÀཡ¿µ¡±£¨hhc£¬human health care£©µÄÆóÒµÀíÄ´´Á¢ºã¾ÃÆóÒµÉç»á¼ÛÖµºÍÓ°ÏìµÄÔ˶¯¡£ng28ÄϹ¬½«¼ÌÐøÔöÇ¿ÓëÈ«Çòͬ°éµÄÏàÖú£¬Îª¼õÇáÃæÁÙ±»ºöÊÓµÄÈÈ´ø²¡Ñ¬È¾Î£º¦µÄÈ˶Խ¡¿µµÄ½¹ÂǺÍËõС»¼ÓÐÕâЩ¼²²¡»¼ÕߵĽ¡¿µ²î±ð£¬×ö³öТ¾´¡£
Media Inquiries: Public Relations Department, Eisai Co., Ltd. +81-(0)3-3817-5120